FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Raleigh Bowden

Research Profile

Procedures

Disorders

Living Beings

Chemicals & Drugs

Concepts & Ideas

Anatomy

Bronchoalveolar Lavage Fluid

Co-author Network

Publications

TOP 3
Michael Boeckh; Hyung W Kim; Mary E D Flowers; Joel D Meyers; Raleigh A Bowden
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.
Michael Boeckh; Wendy Leisenring; Stanley R Riddell; Raleigh A Bowden; Meei-Li Huang; David Myerson; Terry Stevens-Ayers; Mary E D Flowers; Terri Cunningham; Lawrence Corey
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.
Kai Hübel; Rachel A Carter; W Conrad Liles; David C Dale; Thomas H Price; Raleigh A Bowden; Scott D Rowley; Thomas R Chauncey; William I Bensinger; Michael Boeckh
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Raleigh Bowden (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Michael Boeckh; Hyung W Kim; Mary E D Flowers; Joel D Meyers; Raleigh A Bowden
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.
Blood 2006;107(5):1800-5.
2003: Michael Boeckh; Wendy Leisenring; Stanley R Riddell; Raleigh A Bowden; Meei-Li Huang; David Myerson; Terry Stevens-Ayers; Mary E D Flowers; Terri Cunningham; Lawrence Corey
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.
Blood 2003;101(2):407-14.
2002: Kai Hübel; Rachel A Carter; W Conrad Liles; David C Dale; Thomas H Price; Raleigh A Bowden; Scott D Rowley; Thomas R Chauncey; William I Bensinger; Michael Boeckh
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors.
Transfusion 2002;42(11):1414-21.
2001: Michael Boeckh; M M Berrey; Raleigh A Bowden; SW Crawford; �James F Balsley; Lawrence Corey
Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.
The Journal of infectious diseases 2001;184(3):350-4.
2001: Raoul Herbrecht; V Letscher-Bru; Raleigh A Bowden; S Kusne; Elias J Anaissie; John Graybill; G A Noskin; E Andrès; Larry Pietrelli
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(7):460-6.
2001: Michael Boeckh; Raleigh A Bowden; Barry Storer; Nelson J Chao; Ricardo Spielberger; D K Tierney; Ghislaine Gallez-Hawkins; T Cunningham; Karl G Blume; D Levitt; John A Zaia
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(6):343-51.
2000: Kieren Marr; K Seidel; M A Slavin; Raleigh A Bowden; H Gary Schoch; Mary E D Flowers; Lawrence Corey; Michael Boeckh
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.
Blood 2000;96(6):2055-61.
2000: Thomas H Price; Raleigh A Bowden; Michael Boeckh; J Bux; K Nelson; W Conrad Liles; David C Dale
Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation.
Blood 2000;95(11):3302-9.
2000: Kieren Marr; K Seidel; Theodore C White; Raleigh A Bowden
Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.
The Journal of infectious diseases 2000;181(1):309-16.
1999: Michael A Amantea; Raleigh A Bowden; A Forrest; Peter Working; MS Newman; RD Mamelok
The population pharmacokinetics of amphotericin B colloidal dispersion in patients receiving bone marrow transplants.
Chemotherapy 1999;45 Suppl 1():48-53.
1999: M Boeckh; Raleigh A Bowden; T Gooley; David Myerson; L Corey
Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients.
Blood 1999;93(5):1781-2.
1999: Lyle Feinstein; K Seidel; J Jocum; Raleigh A Bowden; Claudio Anasetti; H Joachim Deeg; Mary E D Flowers; E Kansu; Paul J Martin; Richard A Nash; Jan Storek; R Etzioni; F R Applebaum; John A Hansen; Rainer Storb; Keith M Sullivan
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(6):369-78.
1998: Jo-Anne H van Burik; R W Schreckhise; Theodore C White; Raleigh A Bowden; David Myerson
Comparison of six extraction techniques for isolation of DNA from filamentous fungi.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36(5):299-303.
1998: Michael Boeckh; T A Gooley; Raleigh A Bowden
Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemia.
The Journal of infectious diseases 1998;178(4):1153-7.
1998: Kieren Marr; Chris N Lyons; Tige R Rustad; Raleigh A Bowden; Theodore C White; T Rustad
Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.
Antimicrobial agents and chemotherapy 1998;42(10):2584-9.
1998: Mary H White; Raleigh A Bowden; Eric S Sandler; M L Graham; Gary A Noskin; John R Wingard; M Goldman; Jo-Anne H van Burik; A McCabe; J S Lin; Marc Gurwith; Carole B Miller
Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(2):296-302.
1998: J H van Burik; Wendy Leisenring; David Myerson; R C Hackman; Howard M Shulman; G E Sale; Raleigh A Bowden; George B McDonald
The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.
Medicine 1998;77(4):246-54.
1998: P Lenssen; Barbara Bruemmer; Raleigh A Bowden; Ted Gooley; Saundra N Aker; D Mattson
Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation.
The American journal of clinical nutrition 1998;67(5):927-33.
1998: Jo-Anne H van Burik; David Myerson; R W Schreckhise; Raleigh A Bowden
Panfungal PCR assay for detection of fungal infection in human blood specimens.
Journal of clinical microbiology 1998;36(5):1169-75.
1998: Theodore C White; Kieren Marr; Raleigh A Bowden
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.
Clinical microbiology reviews 1998;11(2):382-402.
1998: Michael Boeckh; John A Zaia; D Jung; S Skettino; Thomas R Chauncey; Raleigh A Bowden
A study of the pharmacokinetics, antiviral activity, and tolerability of oral ganciclovir for CMV prophylaxis in marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(1):13-9.
1997: Kieren Marr; Theodore C White; Jo-Anne H van Burik; Raleigh A Bowden
Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(4):908-10.
1997: B Salzberger; Raleigh A Bowden; Robert C Hackman; C Davis; Michael Boeckh
Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome.
Blood 1997;90(6):2502-8.
1997: Michael Boeckh; Ghislaine Gallez-Hawkins; David Myerson; John A Zaia; Raleigh A Bowden
Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.
Transplantation 1997;64(1):108-13.
1997: Jo-Anne H van Burik; Robert C Hackman; S Q Nadeem; John W Hiemenz; Mary H White; Mary E D Flowers; Raleigh A Bowden
Nocardiosis after bone marrow transplantation: a retrospective study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(6):1154-60.
1997: Anna Wald; Wendy Leisenring; Jo-Anne H van Burik; Raleigh A Bowden
Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation.
The Journal of infectious diseases 1997;175(6):1459-66.
1997: Ajit P Limaye; Raleigh A Bowden; David Myerson; Michael Boeckh
Cytomegalovirus disease occurring before engraftment in marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):830-5.
1997: Mary H White; Elias J Anaissie; S Kusne; John R Wingard; John W Hiemenz; A Cantor; Marc Gurwith; C Du Mond; RD Mamelok; Raleigh A Bowden
Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(4):635-42.
1997: W Conrad Liles; J E Huang; Jo-Anne H van Burik; Raleigh A Bowden; David C Dale
Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens.
The Journal of infectious diseases 1997;175(4):1012-5.
1997: Raleigh A Bowden
Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience.
The American journal of medicine 1997;102(3A):27-30; discussion 42-3.
1996: Michael Boeckh; T A Gooley; David Myerson; T Cunningham; Gary Schoch; Raleigh A Bowden
Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study.
Blood 1996;88(10):4063-71.
1996: David M Lewinsohn; Raleigh A Bowden; D Mattson; S W Crawford
Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation.
Antimicrobial agents and chemotherapy 1996;40(11):2555-7.
1996: Michael Boeckh; T Stevens-Ayers; Raleigh A Bowden
Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation.
The Journal of infectious diseases 1996;174(5):907-12.
1996: Raleigh A Bowden; M Cays; T Gooley; R D Mamelok; Jo-Anne H van Burik
Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant.
The Journal of infectious diseases 1996;173(5):1208-15.
1996: M R Oliver; W C Van Voorhis; Michael Boeckh; D Mattson; Raleigh A Bowden
Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(3):521-4.
1996: K M Sullivan; Jan Storek; K J Kopecky; J Jocom; Gary Longton; M Flowers; MF Siadak; J Nims; Robert P Witherspoon; Claudio Anasetti; Frederick R Appelbaum; Raleigh A Bowden; C Dean Buckner; SW Crawford; H Joachim Deeg; John A Hansen; George B McDonald; Jean E Sanders; Rainer Storb
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(1):44-53.
1995: Raleigh A Bowden; Sherrill J Slichter; M Sayers; Daniel Weisdorf; M Cays; Gary Schoch; M Banaji; R Haake; K Welk; Lloyd Fisher; J McCullough; Wesley J Miller
A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
Blood 1995;86(9):3598-603.
1995: Michael Boeckh; T A Gooley; P Reusser; C Dean Buckner; Raleigh A Bowden
Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation.
The Journal of infectious diseases 1995;172(4):939-43.
1995: Michael A Amantea; Raleigh A Bowden; A Forrest; Peter Working; MS Newman; RD Mamelok
Population pharmacokinetics and renal function-sparing effects of amphotericin B colloidal dispersion in patients receiving bone marrow transplants.
Antimicrobial agents and chemotherapy 1995;39(9):2042-7.
1995: M A Slavin; B Osborne; R Adams; M J Levenstein; H Gary Schoch; A R Feldman; J D Meyers; Raleigh A Bowden
Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
The Journal of infectious diseases 1995;171(6):1545-52.
1995: Raleigh A Bowden
Transfusion-transmitted cytomegalovirus infection.
Hematology/oncology clinics of North America 1995;9(1):155-66.
1994: M A Slavin; T A Gooley; Raleigh A Bowden
Prediction of cytomegalovirus pneumonia after marrow transplantation from cellular characteristics and cytomegalovirus culture of bronchoalveolar lavage fluid.
Transplantation 1994;58(8):915-9.
1994: Michael E. Hagensee; J E Bauwens; B Kjos; Raleigh A Bowden
Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(3):402-8.
1994: Michael Boeckh; P M Woogerd; T Stevens-Ayers; C G Ray; Raleigh A Bowden
Factors influencing detection of quantitative cytomegalovirus antigenemia.
Journal of clinical microbiology 1994;32(3):832-4.
1994: Michael Boeckh; David Myerson; Raleigh A Bowden
Early detection and treatment of cytomegalovirus infections in marrow transplant patients: methodological aspects and implications for therapeutic interventions.
Bone marrow transplantation 1994;14 Suppl 4():S66-70.
1993: Reginald Clift; J A Bianco; Frederick R Appelbaum; C Dean Buckner; jack w singer; L Bakke; William I Bensinger; Raleigh A Bowden; George B McDonald; M Schubert
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Blood 1993;82(7):2025-30.
1993: David Myerson; P A Lingenfelter; C A Gleaves; J D Meyers; Raleigh A Bowden
Diagnosis of cytomegalovirus pneumonia by the polymerase chain reaction with archived frozen lung tissue and bronchoalveolar lavage fluid.
American journal of clinical pathology 1993;100(4):407-13.
1993: R W Cone; Robert C Hackman; Meei-Li Huang; Raleigh A Bowden; J D Meyers; M Metcalf; Judy Zeh; Rhoda Ashley; Lawrence Corey
Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation.
The New England journal of medicine 1993;329(3):156-61.
1993: M A Slavin; R R Bindra; C A Gleaves; M B Pettinger; Raleigh A Bowden
Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients.
Antimicrobial agents and chemotherapy 1993;37(6):1360-3.
1993: Raleigh A Bowden; Motomi Mori; S Dobbs; Robert C Hackman; K Kopecky; S Crawford
Mononuclear cell reconstitution in the lung after marrow transplantation. Lack of influence of cytomegalovirus pneumonia, irradiation, and graft-versus-host disease.
Transplantation 1993;55(3):557-61.
1993: J M Goodrich; Raleigh A Bowden; Lloyd Fisher; C Keller; Gary Schoch; J D Meyers
Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant.
Annals of internal medicine 1993;118(3):173-8.
1993: David H Spach; J E Bauwens; David Myerson; M M Mustafa; Raleigh A Bowden
Cytomegalovirus-induced hemorrhagic cystitis following bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16(1):142-4.
1992: M A Slavin; C A Gleaves; H Gary Schoch; Raleigh A Bowden
Quantification of cytomegalovirus in bronchoalveolar lavage fluid after allogeneic marrow transplantation by centrifugation culture.
Journal of clinical microbiology 1992;30(11):2776-9.
1992: Richard A Nash; Margaret Sullivan Pepe; Rainer Storb; Gary Longton; M Pettinger; Claudio Anasetti; Frederick R Appelbaum; Raleigh A Bowden; H Joachim Deeg; Kristine C Doney
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Blood 1992;80(7):1838-45.
1992: J E Bauwens; David H Spach; T W Schacker; M M Mustafa; Raleigh A Bowden
Bordetella bronchiseptica pneumonia and bacteremia following bone marrow transplantation.
Journal of clinical microbiology 1992;30(9):2474-5.
1992: Michael Boeckh; Raleigh A Bowden; J M Goodrich; M Pettinger; J D Meyers
Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation.
Blood 1992;80(5):1358-64.
1992: J R Johnson; S Egaas; C A Gleaves; R Hackman; Raleigh A Bowden
Hepatitis due to herpes simplex virus in marrow-transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(1):38-45.
1991: Raleigh A Bowden; Lloyd Fisher; K Rogers; M Cays; J D Meyers
Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant.
The Journal of infectious diseases 1991;164(3):483-7.
1991: Raleigh A Bowden; Sherrill J Slichter; M H Sayers; Motomi Mori; M J Cays; J D Meyers
Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant.
Blood 1991;78(1):246-50.
1990: K M Sullivan; K J Kopecky; J Jocom; Lloyd Fisher; C Dean Buckner; J D Meyers; G W Counts; Raleigh A Bowden; F B Peterson; Robert P Witherspoon
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.
The New England journal of medicine 1990;323(11):705-12.
1990: Raleigh A Bowden; S Dobbs; D Amos; J D Meyers
Comparison of interleukin 2 and gamma-interferon production by peripheral blood mononuclear cells in response to cytomegalovirus after marrow transplantation.
Transplantation 1990;50(1):38-42.
1990: Raleigh A Bowden; R W Coombs; B H Nikora; C Bigelow; G E Sale; ED Thomas; J D Meyers; Lawrence Corey
Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation.
The American journal of medicine 1990;88(5N):49N-52N.
1989: C A Gleaves; David Myerson; Raleigh A Bowden; Robert C Hackman; J D Meyers
Direct detection of cytomegalovirus from bronchoalveolar lavage samples by using a rapid in situ DNA hybridization assay.
Journal of clinical microbiology 1989;27(11):2429-32.
1988: E C Reed; Raleigh A Bowden; P S Dandliker; Kathy Lilleby; J D Meyers
Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants.
Annals of internal medicine 1988;109(10):783-8.
1988: Raleigh A Bowden; S Dobbs; K J Kopecky; S Crawford; J D Meyers
Increased cytotoxicity against cytomegalovirus-infected target cells by bronchoalveolar lavage cells from bone marrow transplant recipients with cytomegalovirus pneumonia.
The Journal of infectious diseases 1988;158(4):773-9.
1988: SW Crawford; Raleigh A Bowden; Robert C Hackman; C A Gleaves; J D Meyers; Joan G Clark
Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture.
Annals of internal medicine 1988;108(2):180-5.
1987: Raleigh A Bowden; J Digel; E C Reed; J D Meyers
Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses.
The Journal of infectious diseases 1987;156(6):899-903.
1987: Raleigh A Bowden; M Sayers; C A Gleaves; M Banaji; B Newton; J D Meyers
Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks.
Transfusion 1987;27(6):478-81.
1987: E C Reed; Raleigh A Bowden; P S Dandliker; C A Gleaves; J D Meyers
Efficacy of cytomegalovirus immunoglobulin in marrow transplant recipients with cytomegalovirus pneumonia.
The Journal of infectious diseases 1987;156(4):641-5.
1987: F B Petersen; Raleigh A Bowden; Mark D Thornquist; J D Meyers; C Dean Buckner; G W Counts; N Nelson; B A Newton; K M Sullivan; J McIver
The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients.
Bone marrow transplantation 1987;2(2):141-7.
1986: Raleigh A Bowden; M Sayers; N Flournoy; B Newton; M Banaji; ED Thomas; J D Meyers
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.
The New England journal of medicine 1986;314(16):1006-10.